Skip to content

OARtrac System with Skin Sensors

by Radiadyne, LLC

510(k) K150719

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK150719 Date16 Jun 2015ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
NZT
Device Class
Class II
Regulation
21 CFR Part 892.5050
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The OARtrac System with Skin Sensors is a dosimeter for ionizing radiation, implanted, as defined in the device classification. It is indicated for use when adhered to the skin using medical grade adhesive and with a medical grade bolus buildup placed directly on top of the sensor, providing near real-time, multi-point radiation dose monitoring during cancer treatment.

The system is supplied as a pre-calibrated device and is used in radiology settings. It is authorized under FDA 510(k) clearance K150719, classified as a Class II device with product code NZT, and is substantially equivalent to a predicate device. The device is not described as sterile, single-use, reusable, or MRI-safe in the provided data, and no storage conditions are specified.

Other devices from Radiadyne

Questions

AI-generated answers, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical purpose does the OARtrac System with Skin Sensors serve?

    It is a dosimeter designed to monitor ionizing radiation dose at multiple points on the patient’s skin in near real‑time, helping clinicians verify that the prescribed radiation dose is being delivered accurately during cancer therapy.

  • How is the device applied and what additional components are needed?

    The sensor is adhered to the patient’s skin using a medical‑grade adhesive, and a medical‑grade bolus buildup is placed directly over the sensor. These components together ensure proper coupling of the radiation field to the sensor for accurate dose measurement.

  • Is the OARtrac System supplied ready for use or does it require calibration?

    The system is supplied as a pre‑calibrated device, meaning the manufacturer has performed the necessary calibration before shipment, so the user does not need to perform additional calibration steps before clinical use.

  • Can the OARtrac System be reused or is it a single‑use product?

    The provided data do not specify sterility, single‑use, or reusable status, so the intended reuse classification is unclear. Users should consult the manufacturer’s labeling or instructions for guidance on reuse or disposal.

  • What regulatory clearance does the OARtrac System have?

    The device received FDA 510(k) clearance (K150719) as a Class II dosimeter (product code NZT), indicating it is substantially equivalent to a legally marketed predicate device.